{"version":"1.0","provider_name":"Times South Africa","provider_url":"https:\/\/timessouthafrica.com","author_name":"TSA","author_url":"https:\/\/timessouthafrica.com\/author\/tsa\/","title":"Vela Diagnostics pr\u00e9sente ses panels de s\u00e9quen\u00e7age des g\u00e8nes du cancer cibl\u00e9s (60 g\u00e8nes) et complets (525 g\u00e8nes) bas\u00e9s sur les NGS - Times South Africa","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"AUPbxg45Js\"><a href=\"https:\/\/timessouthafrica.com\/vela-diagnostics-presente-ses-panels-de-sequencage-des-genes-du-cancer-cibles-60-genes-et-complets-525-genes-bases-sur-les-ngs\/\">Vela Diagnostics pr\u00e9sente ses panels de s\u00e9quen\u00e7age des g\u00e8nes du cancer cibl\u00e9s (60 g\u00e8nes) et complets (525 g\u00e8nes) bas\u00e9s sur les NGS<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/timessouthafrica.com\/vela-diagnostics-presente-ses-panels-de-sequencage-des-genes-du-cancer-cibles-60-genes-et-complets-525-genes-bases-sur-les-ngs\/embed\/#?secret=AUPbxg45Js\" width=\"600\" height=\"338\" title=\"&#8220;Vela Diagnostics pr\u00e9sente ses panels de s\u00e9quen\u00e7age des g\u00e8nes du cancer cibl\u00e9s (60 g\u00e8nes) et complets (525 g\u00e8nes) bas\u00e9s sur les NGS&#8221; &#8212; Times South Africa\" data-secret=\"AUPbxg45Js\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","description":"HAMBOURG, Allemagne, 28 mars\u00a02022\u00a0 \/PRNewswire\/\u00a0\u2014\u00a0Vela Diagnostics a annonc\u00e9 aujourd\u2019hui le lancement de ses nouveaux panels de s\u00e9quen\u00e7age OncoKey\u00ae\u00a0SL 60 et 525 Plus. Ces panels bas\u00e9s sur les syst\u00e8mes de s\u00e9quen\u00e7age de nouvelle g\u00e9n\u00e9ration\u00a0(NGS) sont con\u00e7us pour d\u00e9tecter les biomarqueurs d\u2019ADN et d\u2019ARN du cancer \u00e0 partir d\u2019\u00e9chantillons de tissus fix\u00e9s au formol et inclus en [\u2026]"}